Net loss of Beryl Drugs reported to Rs 0.35 crore in the quarter ended March 2024 as against net profit of Rs 0.06 crore during the previous quarter ended March 2023. Sales declined 51.23% to Rs 2.98 crore in the quarter ended March 2024 as against Rs 6.11 crore during the previous quarter ended March 2023.For the full year,net profit remain constant at Rs 0.77 crore in the year ended March 2024 and also during the previous year ended March 2023. Sales declined 0.60% to Rs 26.73 crore in the year ended March 2024 as against Rs 26.89 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales2.986.11 -51 26.7326.89 -1 OPM %1.014.26 -9.998.26 - PBDT-0.100.20 PL 2.211.80 23 PBT-0.420.05 PL 1.010.99 2 NP-0.350.06 PL 0.770.77 0 Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 20 April 2024.Powered by Capital Market - Live News

Net profit of Beryl Drugs rose 121.43% to Rs 0.31 crore in the quarter ended December 2023 as against Rs 0.14 crore during the previous quarter ended December 2022. Sales declined 6.50% to Rs 7.62 crore in the quarter ended December 2023 as against Rs 8.15 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales7.628.15 -7 OPM %10.378.71 - PBDT0.680.59 15 PBT0.370.37 0 NP0.310.14 121 Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 12 February 2024. The meeting would commence at 2.00 pm.Powered by Capital Market - Live News